Microenvironmental host–microbe interactions in chronic inflammatory skin diseases
Several microbiome studies have recently demonstrated microbial dysbiosis in various
chronic inflammatory skin diseases, and it is considered an important role in the …
chronic inflammatory skin diseases, and it is considered an important role in the …
[HTML][HTML] Hidradenitis suppurativa
K Ballard, V Shuman - StatPearls, 2024 - statpearls.com
Hidradenitis suppurativa (acne inversa or Verneuil disease) is a chronic inflammatory skin
condition of follicular occlusion with lesions including deep-seated nodules and abscesses …
condition of follicular occlusion with lesions including deep-seated nodules and abscesses …
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real …
S Haselgruber, P Fernández-Crehuet-Serrano… - Dermatology and …, 2024 - Springer
Introducion The concept of a window of opportunity in hidradenitis suppurativa (HS)
management suggests that early initiation of biological therapy leads to better outcomes …
management suggests that early initiation of biological therapy leads to better outcomes …
Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: A cohort study
Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: a
cohort study Page 1 Journal Pre-proof Infliximab shows superior drug survival among …
cohort study Page 1 Journal Pre-proof Infliximab shows superior drug survival among …
[引用][C] Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa
Dear Editor, Hidradenitis suppurativa (HS) is a chronic skin disease with limited effective
treatments, and the identification of novel therapeutic drugs are essential for disease …
treatments, and the identification of novel therapeutic drugs are essential for disease …
[引用][C] Prolonged drug survival of adalimumab in hidradenitis suppurativa: The importance of early intervention
MP Konstantinou, K Krasagakis - Journal of the European …, 2025 - Wiley Online Library
PIONEER I and II trials proved the efficacy and safety of adalimumab for moderate-to-severe
hidradenitis suppurativa (HS). 1 When stringent eligibility criteria are applied in randomized …
hidradenitis suppurativa (HS). 1 When stringent eligibility criteria are applied in randomized …